Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of thiazide diuretics, calcium polystyrene sulfonate, and sodium zirconium cyclosilicate for hyperkalemia in chronic kidney disease
TCTR20250519005Phase 3Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Apr 2025
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of calcium polystyrene sulfonate, sodium zirconium cyclosilicate in hyperkalemia, chronic kidney disease (CKD), sponsored by Ratchadaphiseksomphot Endowment Fund. Started Apr 2025; status: completed.
02
Drugs
calcium polystyrene sulfonatesodium zirconium cyclosilicate
03
Conditions
hyperkalemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on TCTR20250519005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250519005.